{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T21:57:42Z","timestamp":1794607062099,"version":"4.9.1"},"reference-count":96,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,1]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND AND OBJECTIVES<\/jats:title>\n                    <jats:p>Current routine immunizations for children aged \u226410 years in the United States in 2019 cover 14 vaccine-preventable diseases. We characterize the public-health impact of vaccination by providing updated estimates of disease incidence with and without universally recommended pediatric vaccines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>Prevaccine disease incidence was obtained from published data or calculated using annual case estimates from the prevaccine period and United States population estimates during the same period. Vaccine-era incidence was calculated as the average incidence over the most recent 5 years of available surveillance data or obtained from published estimates (if surveillance data were not available). We adjusted for underreporting and calculated the percent reduction in overall and age-specific incidence for each disease. We multiplied prevaccine and vaccine-era incidence rates by 2019 United States population estimates to calculate annual number of cases averted by vaccination.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Routine immunization reduced the incidence of all targeted diseases, leading to reductions in incidence ranging from 17% (influenza) to 100% (diphtheria, Haemophilus influenzae type b, measles, mumps, polio, and rubella). For the 2019 United States population of 328 million people, these reductions equate to &amp;gt;24 million cases of vaccine-preventable disease averted. Vaccine-era disease incidence estimates remained highest for influenza (13\u2009412 per 100\u2009000) and Streptococcus pneumoniae-related acute otitis media (2756 per 100\u2009000).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>Routine childhood immunization in the United States continues to yield considerable sustained reductions in incidence across all targeted diseases. Efforts to maintain and improve vaccination coverage are necessary to continue experiencing low incidence levels of vaccine-preventable diseases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1542\/peds.2021-056013","type":"journal-article","created":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T00:08:00Z","timestamp":1657670880000},"source":"Crossref","is-referenced-by-count":71,"title":["Impact of Routine Childhood Immunization in Reducing Vaccine-Preventable Diseases in the United States"],"prefix":"10.1542","volume":"150","author":[{"given":"Sandra E.","family":"Talbird","sequence":"first","affiliation":[{"name":"aRTI Health Solutions, Research Triangle Park, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Carrico","sequence":"additional","affiliation":[{"name":"aRTI Health Solutions, Research Triangle Park, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"La","sequence":"additional","affiliation":[{"name":"aRTI Health Solutions, Research Triangle Park, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Carias","sequence":"additional","affiliation":[{"name":"bMerck & Co, Inc, Rahway, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary S.","family":"Marshall","sequence":"additional","affiliation":[{"name":"cNorton Children\u2019s and University of Louisville School of Medicine, Louisville, Kentucky"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig S.","family":"Roberts","sequence":"additional","affiliation":[{"name":"bMerck & Co, Inc, Rahway, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Ting","family":"Chen","sequence":"additional","affiliation":[{"name":"bMerck & Co, Inc, Rahway, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mawuli K.","family":"Nyaku","sequence":"additional","affiliation":[{"name":"bMerck & Co, Inc, Rahway, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2022,8,22]]},"reference":[{"issue":"16","key":"2023110816292056900_B1","first-page":"352","article-title":"Benefits from immunization during the vaccines for children program era - United States, 1994-2013","volume":"63","author":"Whitney","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2023110816292056900_B2","first-page":"22","article-title":"The principles of disease elimination and eradication","volume":"76","author":"Dowdle","year":"1998","journal-title":"Bull World Health Organ"},{"issue":"18","key":"2023110816292056900_B3","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1001\/jama.298.18.2155","article-title":"Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States","volume":"298","author":"Roush","year":"2007","journal-title":"JAMA"},{"key":"2023110816292056900_B4","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jpeds.2018.05.047","article-title":"Ambulatory visits for otitis media before and after the introduction of pneumococcal conjugate vaccination","volume":"201","author":"Kawai","year":"2018","journal-title":"J Pediatr"},{"key":"2023110816292056900_B5","unstructured":"Centers for Disease Control and Prevention (CDC)\n          . Recommended child and adolescent immunization schedule for ages 18 years or younger, United States, 2019. Available at: https:\/\/www.cdc.gov\/vaccines\/schedules\/hcp\/imz\/child-adolescent.html. Accessed October 15, 2021"},{"issue":"22","key":"2023110816292056900_B6","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1056\/NEJMms1215400","article-title":"Contagious diseases in the United States from 1888 to the present","volume":"369","author":"van Panhuis","year":"2013","journal-title":"N Engl J Med"},{"issue":"3","key":"2023110816292056900_B7","doi-asserted-by":"crossref","first-page":"e2021056007","DOI":"10.1542\/peds.2021-056007","volume":"150","author":"Carrico","year":"2022","journal-title":"Pediatrics"},{"key":"2023110816292056900_B8","unstructured":"US Census Bureau PD\n          . Annual estimates of the resident population by single year of age and sex for the United States: April 1, 2010 to July 1, 2019 (NC-EST2019-SYASEXN). Available at: https:\/\/www.census.gov\/topics\/population.html. Accessed November 18, 2021"},{"issue":"4","key":"2023110816292056900_B9","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1542\/peds.2013-0698","article-title":"Economic evaluation of the routine childhood immunization program in the United States, 2009","volume":"133","author":"Zhou","year":"2014","journal-title":"Pediatrics"},{"issue":"14","key":"2023110816292056900_B10","doi-asserted-by":"crossref","first-page":"763","DOI":"10.2307\/4579202","article-title":"Age incidence of the common communicable diseases in children: a study of case rates among all children and among children not previously attacked and of death rates and the estimated case fatality","volume":"44","author":"Collins","year":"1929","journal-title":"Public Health Rep"},{"key":"2023110816292056900_B11","unstructured":"Centers for Disease Control and Prevention (CDC)\n          . National notifiable diseases surveillance system. 2018 annual tables of infectious diseases data. Available at: https:\/\/www.cdc.gov\/nndss\/infectious- tables.html. Accessed May 20, 2020"},{"key":"2023110816292056900_B12","unstructured":"Centers for Disease Control and Prevention (CDC)\n          . National notifiable diseases surveillance system. 2017 annual tables of infectious diseases data. Available at: https:\/\/www.cdc.gov\/nndss\/infectious- tables.html. Accessed April 2, 2019"},{"key":"2023110816292056900_B13","unstructured":"Centers for Disease Control and Prevention (CDC)\n          . National notifiable diseases surveillance system. 2016 annual tables of infectious diseases data. Available at: https:\/\/wwwn.cdc.gov\/nndss\/infectious-tables.html. Accessed May 1, 2020"},{"issue":"53","key":"2023110816292056900_B14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.mm6453a1","article-title":"Summary of notifiable infectious diseases and conditions - United States, 2015","volume":"64","author":"Adams","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"54","key":"2023110816292056900_B15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.mm6354a1","article-title":"Summary of notifiable infectious diseases and conditions - United States, 2014","volume":"63","author":"Adams","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"53","key":"2023110816292056900_B16","first-page":"1","article-title":"Summary of notifiable diseases, United States. 1990","volume":"39","author":"Centers for Disease Control (CDC)","year":"1991","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"53","key":"2023110816292056900_B17","first-page":"1","article-title":"Summary of notifiable diseases, United States--1991","volume":"40","author":"Centers for Disease Control (CDC)","year":"1992","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"55","key":"2023110816292056900_B18","first-page":"iv-73","article-title":"Summary of notifiable diseases, United States 1992","volume":"41","author":"Centers for Disease Control and Prevention (CDC)","year":"1993","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"53","key":"2023110816292056900_B19","first-page":"i","article-title":"Summary of notifiable diseases, United States, 1993","volume":"42","author":"Centers for Disease Control and Prevention (CDC)","year":"1994","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"53","key":"2023110816292056900_B20","first-page":"1","article-title":"Summary of notifiable diseases, United States 1994","volume":"43","author":"Centers for Disease Control and Prevention (CDC)","year":"1994","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2023110816292056900_B21","first-page":"25","article-title":"National and state population estimates: 1990 to 1994. US Bureau of the Census","author":"Byerly","year":"1995","journal-title":"Curr Popul Rep [Spec Censuses]"},{"key":"2023110816292056900_B22","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s12879-016-1636-6","article-title":"Underreporting of hepatitis A in non-endemic countries: a systematic review and meta-analysis","volume":"16","author":"Savage","year":"2016","journal-title":"BMC Infect Dis"},{"issue":"3","key":"2023110816292056900_B23","doi-asserted-by":"crossref","first-page":"482","DOI":"10.2105\/AJPH.2013.301601","article-title":"Estimating acute viral hepatitis infections from nationally reported cases","volume":"104","author":"Klevens","year":"2014","journal-title":"Am J Public Health"},{"issue":"53","key":"2023110816292056900_B24","first-page":"1","article-title":"Annual summary 1976. Reported morbidity and mortality in the United States","volume":"25","author":"Centers for Disease Control and Prevention (CDC)","year":"1977","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"53","key":"2023110816292056900_B25","first-page":"1","article-title":"Annual summary 1977. Reported morbidity and mortality in the United States","volume":"25","author":"Centers for Disease Control and Prevention (CDC)","year":"1978","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"54","key":"2023110816292056900_B26","first-page":"1","article-title":"Annual summary 1978. Reported morbidity and mortality in the United States","volume":"27","author":"Centers for Disease Control and Prevention (CDC)","year":"1979","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"54","key":"2023110816292056900_B27","first-page":"1","article-title":"Annual summary 1979. reported morbidity and mortality in the United States","volume":"28","author":"Centers for Disease Control (CDC)","year":"1980","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"54","key":"2023110816292056900_B28","first-page":"1","article-title":"Annual summary 1980. Reported morbidity and mortality in the United States","volume":"29","author":"Centers for Disease Control (CDC)","year":"1981","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"2023110816292056900_B29","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1542\/peds.110.4.653","article-title":"Impact of universal Haemophilus influenzae type b vaccination starting at 2 months of age in the United States: an economic analysis","volume":"110","author":"Zhou","year":"2002","journal-title":"Pediatrics"},{"key":"2023110816292056900_B30","unstructured":"Centers for Disease Control and Prevention (CDC)\n          . Active bacterial core surveillance report, emerging infections program network, Haemophilus influenza 2013. Available at: www.cdc.gov\/abcs\/reports-findings\/survreports\/hi13.pdf. Accessed May 11, 2020"},{"key":"2023110816292056900_B31","unstructured":"Centers for Disease Control and Prevention (CDC)\n          . Active bacterial core surveillance report, emerging infections program network, Haemophilus influenza 2014. Available at: www.cdc.gov\/abcs\/reports-findings\/survreports\/hi14.pdf. Accessed May 11, 2020"},{"key":"2023110816292056900_B32","unstructured":"Centers for Disease Control and Prevention (CDC)\n          . Active bacterial core surveillance report, emerging infections program network, Haemophilus influenza 2015. Available at: https:\/\/www.cdc.gov\/abcs\/reports-findings\/survreports\/hib15.pdf. Accessed May 11, 2020"},{"key":"2023110816292056900_B33","unstructured":"Centers for Disease Control and Prevention (CDC)\n          . Active bacterial core surveillance report, emerging infections program network, Haemophilus influenza 2016. Available at: www.cdc.gov\/abcs\/reports-findings\/survreports\/hi16.pdf. Accessed May 11, 2020"},{"key":"2023110816292056900_B34","unstructured":"Centers for Disease Control and Prevention (CDC)\n          . Active bacterial core surveillance report, emerging infections program network, Haemophilus influenza 2017. Available at: www.cdc.gov\/abcs\/reports-findings\/survreports\/hi17.pdf Accessed May 11, 2020"},{"key":"2023110816292056900_B35","unstructured":"Centers for Disease Control and Prevention (CDC)\n          . Estimated influenza illnesses, medical visits, hospitalization, and deaths in the United States \u2013 2014-2015 influenza season. Available at: https:\/\/www.cdc.gov\/flu\/about\/burden\/2014-2015.html. Accessed May 15, 2020"},{"key":"2023110816292056900_B36","unstructured":"Centers for Disease Control and Prevention (CDC)\n          . Estimated influenza illnesses, medical visits, hospitalization, and deaths in the United States \u2013 2015-2016 influenza season. Available at: https:\/\/www.cdc.gov\/flu\/about\/burden\/2015-2016.html. Accessed May 15, 2020"},{"key":"2023110816292056900_B37","unstructured":"Centers for Disease Control and Prevention (CDC)\n          . Estimated influenza illnesses, medical visits, hospitalization, and deaths in the United States \u2013 2016-2017 influenza season. Available at: https:\/\/www.cdc.gov\/flu\/about\/burden\/2016-2017.html. Accessed May 15, 2020"},{"key":"2023110816292056900_B38","unstructured":"Centers for Disease Control and Prevention (CDC)\n          . 2014-2015 estimated influenza illnesses, medical visits, hospitalizations, and deaths averted by vaccination in the United States. Available at: https:\/\/www.cdc.gov\/flu\/about\/burden-averted\/2014-15.htm. Accessed May 16, 2020"},{"key":"2023110816292056900_B39","unstructured":"Centers for Disease Control and Prevention (CDC)\n          . 2015-2016 estimated influenza illnesses, medical visits, hospitalizations, and deaths averted by vaccination in the United States. Available at: https:\/\/www.cdc.gov\/flu\/about\/burden-averted\/2015-16.htm. Accessed May 16, 2020"},{"key":"2023110816292056900_B40","unstructured":"Centers for Disease Control and Prevention (CDC)\n          . 2017-2018 estimated influenza illnesses, medical visits, hospitalizations, and deaths and estimated influenza illnesses, medical visits, hospitalizations, and deaths averted by vaccination in the United States. Available at: https:\/\/www.cdc.gov\/flu\/about\/burden-averted\/2017-2018.htm. Accessed May 16, 2020"},{"key":"2023110816292056900_B41","unstructured":"Centers for Disease Control and Prevention (CDC)\n          . Estimated influenza illnesses, medical visits, hospitalization, and deaths in the United States \u2013 2018-2019 influenza season. Available at: https:\/\/www.cdc.gov\/flu\/about\/burden\/2018-2019.html. Accessed May 15, 2020"},{"issue":"8","key":"2023110816292056900_B42","doi-asserted-by":"crossref","first-page":"e368","DOI":"10.1093\/cid\/ciz1244","article-title":"Effects of influenza vaccination in the United States during the 2018-2019 influenza season","volume":"71","author":"Chung","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2023110816292056900_B43","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1086\/378987","article-title":"An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States","volume":"189","author":"Zhou","year":"2004","journal-title":"J Infect Dis"},{"issue":"7","key":"2023110816292056900_B44","doi-asserted-by":"crossref","first-page":"739","DOI":"10.2105\/AJPH.75.7.739","article-title":"Benefits, risks and costs of immunization for measles, mumps and rubella","volume":"75","author":"White","year":"1985","journal-title":"Am J Public Health"},{"key":"2023110816292056900_B45","volume-title":"A Cost Benefit Analysis of the Measles-Mumps-Rubella (MMR) Vaccine: Report Prepared for the Centers for Disease Control and Prevention","author":"Hatziandreu","year":"1994"},{"key":"2023110816292056900_B46","first-page":"224","article-title":"Medical importance of measles","volume":"103","author":"Langmuir","year":"1962","journal-title":"Am J Dis Child"},{"issue":"6","key":"2023110816292056900_B47","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1056\/NEJM197602052940604","article-title":"Benefit-cost analysis of rubella vaccination policy","volume":"294","author":"Schoenbaum","year":"1976","journal-title":"N Engl J Med"},{"issue":"8","key":"2023110816292056900_B48","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/archpedi.154.8.797","article-title":"Economic evaluation of use of diphtheria, tetanus, and acellular pertussis vaccine or diphtheria, tetanus, and whole-cell pertussis vaccine in the United States, 1997","volume":"154","author":"Ekwueme","year":"2000","journal-title":"Arch Pediatr Adolesc Med"},{"key":"2023110816292056900_B49","unstructured":"US Census Bureau\n          . Historical national population estimates: July 1, 1900 to July 1, 1999. Available at: https:\/\/www.census.gov\/data\/tables\/time-series\/demo\/popest\/pre-1980-national.html. Accessed November 21, 2019"},{"key":"2023110816292056900_B50","unstructured":"Hobbs\n              F\n            , StoopsN. Demographic trends in the 20th century. US Census Bureau. Table 5A. Available at: https:\/\/www.census.gov\/prod\/2002pubs\/censr-4.pdf. Accessed February 3, 2022"},{"issue":"9","key":"2023110816292056900_B51","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1086\/319853","article-title":"Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995-1996","volume":"183","author":"Strebel","year":"2001","journal-title":"J Infect Dis"},{"issue":"21","key":"2023110816292056900_B52","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1001\/jama.1996.03530450062034","article-title":"Prevalence and incidence of adult pertussis in an urban population","volume":"275","author":"Nennig","year":"1996","journal-title":"JAMA"},{"issue":"15","key":"2023110816292056900_B53","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/j.vaccine.2016.02.027","article-title":"Impact and cost-effectiveness of a second tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine dose to prevent pertussis in the United States","volume":"34","author":"Kamiya","year":"2016","journal-title":"Vaccine"},{"issue":"10","key":"2023110816292056900_B54","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1080\/21645515.2016.1186313","article-title":"Estimated incidence of pertussis in people aged &lt;50 years in the United States","volume":"12","author":"Chen","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"2023110816292056900_B55","volume-title":"Cost-Effectiveness of Pertussis Vaccine Substitution for Tetanus Booster in Prevention of Pertussis in Adults 65 years and Older, Presentation to the Advisory Committee on Immunization Practices (ACIP)","author":"Acosta","year":"2012"},{"issue":"2","key":"2023110816292056900_B56","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.vaccine.2019.09.104","article-title":"Economic impact of implementing decennial tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccination in adults in the United States","volume":"38","author":"Havers","year":"2020","journal-title":"Vaccine"},{"key":"2023110816292056900_B57","unstructured":"Centers for Disease Control and Prevention (CDC)\n          . Active bacterial core surveillance report, emerging infections program network, Streptococcus pneumoniae, 1997. Available at: https:\/\/www.cdc.gov\/abcs\/reports-findings\/surv-reports.html. Accessed June 16, 2020"},{"key":"2023110816292056900_B58","unstructured":"Centers for Disease Control and Prevention (CDC)\n          . Active bacterial core surveillance report, emerging infections program network, 1998. Available at: https:\/\/www.cdc.gov\/abcs\/reports-findings\/surv-reports.html. Accessed June 16, 2020"},{"key":"2023110816292056900_B59","unstructured":"Centers for Disease Control and Prevention (CDC)\n          . Active bacterial core surveillance report, emerging infections program network, Streptococcus pneumoniae, 1999. Available at: https:\/\/www.cdc.gov\/abcs\/reports-findings\/surv-reports.html. Accessed June 16, 2020"},{"key":"2023110816292056900_B60","unstructured":"Centers for Disease Control and Prevention (CDC)\n          . Active bacterial core surveillance report, emerging infections program network, Streptococcus pneumoniae, 2013. Available at: https:\/\/www.cdc.gov\/abcs\/reports-findings\/surv-reports.html. Accessed May 11, 2020"},{"key":"2023110816292056900_B61","unstructured":"Centers for Disease Control and Prevention (CDC)\n          . Active bacterial core surveillance report, emerging infections program network, Streptococcus pneumoniae, 2014. Available at: https:\/\/www.cdc.gov\/abcs\/reports-findings\/surv-reports.html. Accessed May 11, 2020"},{"key":"2023110816292056900_B62","unstructured":"Centers for Disease Control and Prevention (CDC)\n          . Active bacterial core surveillance report, emerging infections program network, Streptococcus pneumoniae, 2015. Available at: https:\/\/www.cdc.gov\/abcs\/reports-findings\/surv-reports.html. Accessed May 11, 2020"},{"key":"2023110816292056900_B63","unstructured":"Centers for Disease Control and Prevention (CDC)\n          . Active bacterial core surveillance report, emerging infections program network, Streptococcus pneumoniae, 2016. Available at: https:\/\/www.cdc.gov\/abcs\/reports-findings\/surv-reports.html. Accessed May 11, 2020"},{"key":"2023110816292056900_B64","unstructured":"Centers for Disease Control and Prevention (CDC)\n          . Active bacterial core surveillance report, emerging infections program network, Streptococcus pneumoniae, 2017. Available at: https:\/\/www.cdc.gov\/abcs\/reports-findings\/surv-reports.html Accessed May 11, 2020"},{"issue":"2","key":"2023110816292056900_B65","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1056\/NEJMoa1209165","article-title":"U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination","volume":"369","author":"Griffin","year":"2013","journal-title":"N Engl J Med"},{"issue":"3","key":"2023110816292056900_B66","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1542\/peds.2010-2008","article-title":"Ambulatory visit rates and antibiotic prescribing for children with pneumonia, 1994-2007","volume":"127","author":"Kronman","year":"2011","journal-title":"Pediatrics"},{"issue":"38","key":"2023110816292056900_B67","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1016\/j.vaccine.2008.07.016","article-title":"Impact of the introduction of pneumococcal conjugate vaccine on rates of community acquired pneumonia in children and adults","volume":"26","author":"Nelson","year":"2008","journal-title":"Vaccine"},{"issue":"1","key":"2023110816292056900_B68","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1186\/s12913-018-3529-4","article-title":"Trends in healthcare utilization and costs associated with pneumonia in the United States during 2008-2014","volume":"18","author":"Tong","year":"2018","journal-title":"BMC Health Serv Res"},{"issue":"7","key":"2023110816292056900_B69","doi-asserted-by":"crossref","first-page":"e744","DOI":"10.1016\/S2214-109X(18)30247-X","article-title":"Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000-15","volume":"6","author":"Wahl","year":"2018","journal-title":"Lancet Glob Health"},{"issue":"4","key":"2023110816292056900_B70","doi-asserted-by":"crossref","first-page":"e60273","DOI":"10.1371\/journal.pone.0060273","article-title":"Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques","volume":"8","author":"Said","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"2023110816292056900_B71","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1056\/NEJMoa1405870","article-title":"Community-acquired pneumonia requiring hospitalization among U.S. children","volume":"372","author":"Jain","year":"2015","journal-title":"N Engl J Med"},{"issue":"25","key":"2023110816292056900_B72","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1016\/j.vaccine.2019.04.087","article-title":"Pneumococcal epidemiology among us adults hospitalized for community-acquired pneumonia","volume":"37","author":"Isturiz","year":"2019","journal-title":"Vaccine"},{"issue":"3","key":"2023110816292056900_B73","doi-asserted-by":"crossref","first-page":"e20170181","DOI":"10.1542\/peds.2017-0181","article-title":"Epidemiology of acute otitis media in the postpneumococcal conjugate vaccine era","volume":"140","author":"Kaur","year":"2017","journal-title":"Pediatrics"},{"issue":"1\u20132","key":"2023110816292056900_B74","first-page":"43","article-title":"Poliomyelitis in 1954","volume":"15","author":"Freyche","year":"1956","journal-title":"Bull World Health Organ"},{"issue":"4","key":"2023110816292056900_B75","doi-asserted-by":"crossref","first-page":"108","DOI":"10.5501\/wjv.v1.i4.108","article-title":"History of polio vaccination","volume":"1","author":"Baicus","year":"2012","journal-title":"World J Virol"},{"issue":"4","key":"2023110816292056900_B76","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1542\/peds.2006-2876","article-title":"Cost-effectiveness and potential impact of rotavirus vaccination in the United States","volume":"119","author":"Widdowson","year":"2007","journal-title":"Pediatrics"},{"issue":"9","key":"2023110816292056900_B77","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/INF.0000000000001988","article-title":"Rotavirus vaccines and health care utilization for diarrhea in US children, 2001 to 2015","volume":"37","author":"Getachew","year":"2018","journal-title":"Pediatr Infect Dis J"},{"issue":"8","key":"2023110816292056900_B78","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.4161\/hv.29511","article-title":"Clinical and cost burden of rotavirus infection before and after introduction of rotavirus vaccines among commercially and Medicaid insured children in the United States","volume":"10","author":"Krishnarajah","year":"2014","journal-title":"Hum Vaccin Immunother"},{"issue":"4","key":"2023110816292056900_B79","doi-asserted-by":"crossref","first-page":"E561","DOI":"10.3390\/vaccines8040561","article-title":"Measuring the benefits of mass vaccination programs in the United States","volume":"8","author":"Magno","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"2023110816292056900_B80","unstructured":"ACIP\n          . Recommended child and adolescent immunization schedule for ages 18 years or younger. Available at: https:\/\/www.cdc.gov\/vaccines\/schedules\/downloads\/child\/0-18yrs-child-combined-schedule.pdf. Accessed November 10, 2021"},{"issue":"17\u201318","key":"2023110816292056900_B81","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0264-410X(02)00777-6","article-title":"Declining pertussis incidence in Sweden following the introduction of acellular pertussis vaccine","volume":"21","author":"Olin","year":"2003","journal-title":"Vaccine"},{"issue":"4","key":"2023110816292056900_B82","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/00006454-198704000-00005","article-title":"Pertussis in Sweden after the cessation of general immunization in 1979","volume":"6","author":"Romanus","year":"1987","journal-title":"Pediatr Infect Dis J"},{"issue":"11","key":"2023110816292056900_B83","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1001\/jama.2016.1353","article-title":"Association between vaccine refusal and vaccine-preventable diseases in the United States: a review of measles and pertussis","volume":"315","author":"Phadke","year":"2016","journal-title":"JAMA"},{"issue":"1","key":"2023110816292056900_B84","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41598-020-80214-3","article-title":"Factors associated with measles resurgence in the United States in the post-elimination era","volume":"11","author":"Dimala","year":"2021","journal-title":"Sci Rep"},{"issue":"40","key":"2023110816292056900_B85","doi-asserted-by":"crossref","first-page":"893","DOI":"10.15585\/mmwr.mm6840e2","article-title":"National update on measles cases and outbreaks - United States, January 1-October 1, 2019","volume":"68","author":"Patel","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"8","key":"2023110816292056900_B86","doi-asserted-by":"crossref","first-page":"e386","DOI":"10.1016\/S2666-5247(21)00094-X","article-title":"Ongoing diphtheria outbreak in Yemen: a cross-sectional and genomic epidemiology study","volume":"2","author":"Badell","year":"2021","journal-title":"Lancet Microbe"},{"issue":"1","key":"2023110816292056900_B87","first-page":"61","article-title":"Diphtheria in metro Manila, the Philippines 2006-2017: a clinical, molecular, and spatial characterization","volume":"72","author":"Saito","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2023110816292056900_B88","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/315535","article-title":"Diphtheria in the Russian Federation in the 1990s","volume":"181","author":"Markina","year":"2000","journal-title":"J Infect Dis"},{"key":"2023110816292056900_B89","unstructured":"ACIP\n          . Recommended childhood and adolescent immunization schedule \u2013 United States, 2005. Available at: https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm5351-Immunizationa1.htm. Accessed November 10, 2021"},{"key":"2023110816292056900_B90","unstructured":"ACIP\n          . Recommended Adult Immunization Schedule \u2013- United States, October 2005\u2013September 2006. Available at: https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm5440-immunizationa1.htm. Accessed November 10, 2021"},{"key":"2023110816292056900_B91","doi-asserted-by":"crossref","first-page":"S164","DOI":"10.1086\/505950","article-title":"The history of rubella and rubella vaccination leading to elimination","volume":"43","author":"Plotkin","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"5","key":"2023110816292056900_B92","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.vaccine.2021.12.064","article-title":"Impact of the COVID-19 pandemic on pediatric and adolescent vaccinations and well child visits in the United States: a database analysis","volume":"40","author":"Kujawski","year":"2022","journal-title":"Vaccine"},{"issue":"1","key":"2023110816292056900_B93","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/jamapediatrics.2021.4251","article-title":"Association of the COVID-19 pandemic with routine childhood vaccination rates and proportion up to date with vaccinations across 8 US health systems in the vaccine safety datalink","volume":"176","author":"DeSilva","year":"2022","journal-title":"JAMA Pediatr"},{"issue":"1","key":"2023110816292056900_B94","doi-asserted-by":"crossref","first-page":"e2020047092","DOI":"10.1542\/peds.2020-047092","article-title":"Pediatric vaccination during the COVID-19 pandemic","volume":"148","author":"Ackerson","year":"2021","journal-title":"Pediatrics"},{"key":"2023110816292056900_B95","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s40471-015-0041-9","article-title":"The history of pertussis (whooping cough); 1906-2015: Facts, myths, and misconceptions","volume":"2","author":"Cherry","year":"2015","journal-title":"Curr Epidemiol Rep"},{"key":"2023110816292056900_B96","unstructured":"Centers for Disease Control and Prevention (CDC)\n          . Pertussis (whooping cough): surveillance and reporting. Available at: https:\/\/www.cdc.gov\/pertussis\/surv-reporting.html. Accessed June 5, 2020"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2021-056013\/1561249\/peds_2021056013.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2021-056013\/1561249\/peds_2021056013.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T11:32:20Z","timestamp":1699443140000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/150\/3\/e2021056013\/188495\/Impact-of-Routine-Childhood-Immunization-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,22]]},"references-count":96,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,8,22]]},"published-print":{"date-parts":[[2022,9,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2021-056013","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,22]]},"article-number":"e2021056013"}}